Indonesia's recent market trends indicate a resilient, cautiously optimistic economic landscape. Its upcoming election is one to watch for investors and businesses.
Decision-making, Factionalism, and Government Relations in Japan January 2024 This article is part of Sandpiper’s Public Affairs Tracker content series on government relations in Asia-Pacific. Here, […]
Our top tips for communicators, marketeers and policymakers looking for their organisation and leadership to shape the debate and to have an impact at Davos 2024.
2024 is bringing a new set of changes, challenges, and opportunities to Asia Pacific’s healthcare sector. Shifting demographics, social changes, and new technologies such as cell and gene therapies, bio-inductive implants, and AI-assisted discovery are expected to reshape the industry.
The challenges faced by globalisation are evolving in real time. For those concentrating on Asia-Pacific, here are the top three worth-noting development.
Robert Magyar, Managing Director of Sandpiper Health, speaks with Telum about his experience, trends and sectors he focuses on, and tips to success in the healthcare communications industry.
Under China's new medical reform, the government has become the largest purchaser of medicine. For pharmaceutical enterprises, favourable policies are the key to market access.
Sandpiper appoints Robert Magyar as the Managing Director of Sandpiper Health, as the multi-award-winning leader in healthcare communications and public affairs plans its next phase of growth.
What are the implications of a new Labour government for the Australian healthcare industry? How brands can adjust their government relations efforts to make connections with the new administration?